Home › Interstitial Lung Diseases › Florida › Miami
Interstitial Lung Diseases clinical trials in Miami, FL
4 studies for Interstitial Lung Diseases are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
RecruitingPhase 3
- Miami VA Healthcare System, Miami
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
RecruitingPhase 2/3
- GSK Investigational Site, Miami
Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
RecruitingPhase 2
- University of Miami Hospital and Clinics, Miami
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
RecruitingPhase 2
- aTyr Investigative Site, Miami
About Interstitial Lung Diseases
Interstitial lung diseases are a group of diseases that inflame or scar the lungs. Breathing in particles (asbestosis, silicosis) causes some types.
More about Interstitial Lung Diseases on MedlinePlus
Interstitial Lung Diseases trials in other cities
- New York City, NY18 studies
- Philadelphia, PA16 studies
- Los Angeles, CA15 studies
- Kansas City, KS14 studies
- Chicago, IL13 studies
- Houston, TX13 studies
- Durham, NC12 studies
- Charleston, SC12 studies
- Aurora, CO11 studies
- Ann Arbor, MI11 studies
- Rochester, MN10 studies
- Boston, MA10 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer31 studies
- Prostate Cancer28 studies
- Obesity27 studies
- Acute Myeloid Leukemia24 studies
- Overweight23 studies
- Ovarian Cancer23 studies
- Metastatic Cancer23 studies
- Ulcerative Colitis22 studies
- Alzheimer's Disease21 studies
- Multiple Myeloma21 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.